NEW YORK ( TheStreet) -- PetMed Express (Nasdaq: PETS) is trading at unusually high volume Monday with one million shares changing hands. It is currently at 4.1 times its average daily volume and trading up 33 cents (+3.5%) at $9.62 as of 3:56 p.m. ET. PetMed Express has a market cap of $195.2 million and is part of the health care sector and drugs industry. Shares are down 47.8% year to date as of the close of trading on Friday. PetMed Express, Inc., doing business as 1-800-PetMeds, operates a pet pharmacy in the United States. It markets non-prescription and prescription pet medications; and other health products for dogs and cats, as well as direct to consumers. The company has a P/E ratio of 11.2, below the average drugs industry P/E ratio of 11.3 and below the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates PetMed Express as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. You can view the full PetMed Express Ratings Report. See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center. Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVUP to 95370 or select from multiple alert options.
More from Markets
How ESG Investing Can Benefit Your Portfolio and 401k
Curious about getting involved in ESG investing? Here's how it can benefit your portfolio.
Dick's Sporting Goods Reportedly Again Mulls Halt to Firearms Sales
Dick's has been the most publicly prominent among the retailers about the subject of firearms sales, CNN reports.
Moderna Stock Surges as FDA Fast Tracks Zika Vaccine
The biotech's investigational Zika vaccine is being evaluated in a Phase I study.
KeyBanc Upgrades Residential Solar Companies on Growth Prospects
Recent weakness in residential solar stocks creates 'an attractive entry point,' KeyBanc analyst says